RT Journal Article
SR Electronic
T1 A Massively Parallel Screen of 5′UTR Mutations Identifies Variants Impacting Translation and Protein Production in Neurodevelopmental Disorder Genes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.02.23297961
DO 10.1101/2023.11.02.23297961
A1 Plassmeyer, Stephen P.
A1 Florian, Colin P.
A1 Kasper, Michael J.
A1 Chase, Rebecca
A1 Mueller, Shayna
A1 Liu, Yating
A1 White, Kelli McFarland
A1 Jungers, Courtney F.
A1 Djuranovic, Slavica Pavlovic
A1 Djuranovic, Sergej
A1 Dougherty, Joseph D.
YR 2023
UL http://medrxiv.org/content/early/2023/11/03/2023.11.02.23297961.abstract
AB De novo mutations cause a variety of neurodevelopmental disorders including autism. Recent whole genome sequencing from individuals with autism has shown that many de novo mutations also occur in untranslated regions (UTRs) of genes, but it is difficult to predict from sequence alone which mutations are functional, let alone causal. Therefore, we developed a high throughput assay to screen the transcriptional and translational effects of 997 variants from 5′UTR patient mutations. This assay successfully enriched for elements that alter reporter translation, identifying over 100 potentially functional mutations from probands. Studies in patient-derived cell lines further confirmed that these mutations can alter protein production in individuals with autism, and some variants fall in genes known to cause syndromic forms of autism, suggesting a diagnosis for these individual patients. Since UTR function varies by cell type, we further optimized this high throughput assay to enable assessment of mutations in neurons in vivo. First, comparing in cellulo to in vivo results, we demonstrate neurons have different principles of regulation by 5′UTRs, consistent with a more robust mechanism for reducing the impact of RNA secondary structure. Finally, we discovered patient mutations specifically altering the translational activity of additional known syndromic genes LRRC4 and ZNF644 in neurons of the brain. Overall our results highlight a new approach for assessing the impact of 5′UTR mutations across cell types and suggest that some cases of neurodevelopmental disorder may be caused by such variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by SFARI 571009 and NIMH R01MH116999 to JDD, IDDRC P50HD103525, R01GM11282 to SD and R01GM136823 to SD and SPDAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Washington University waived ethetic approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll sequencing data, including raw fastq files and processed count files, were deposited to the Gene Expression Omnibus (GEO) database at accession number GSE246381. Unless otherwise stated all analyses and plot creation were performed in R version 4.3.0 with RStudio version 2023.09.0+463. Code and other software used to perform analyses were uploaded to BitBucket at https://bitbucket.org/jdlabteam/fiveprime_mpra_pub/src/main/. For access, please see and follow the directions outlined in the README page. Cartoon depictions of experiments/constructs (Figs 1A-B, 4B, 5A-B, and 6) were created with Biorender.com. Other resources and datasets used are appropriately cited throughout the text.